Hybrid Peptide Nanostructures for Uniform Length Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for controlling the dimension and length distribution of dipeptide nanotubes in solution are limited, hindering the formation of uniform nanostructures with desired mechanical and physical properties for technological applications.
Innovation Solution
The co-assembly of aromatic dipeptides, specifically Boc-FF and FF, at varying molar ratios in solution allows for controlled elongation and length distribution of tubular nanostructures, resulting in hybrid nanostructures with shorter average lengths and narrower length distributions, suitable for reinforcement and dispersion in matrices.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If dipeptide nanotubes are self-assembled in solution using conventional methods, then nanotube formation occurs, but the length distribution is broad and dimensional control is limited
Solution Approach 1:
The patent applies parameter changes by systematically varying the molar ratio of diphenylalanine to end-capped diphenylalanine, the total peptide concentration, and the solvent composition (water/ethanol ratio) to precisely control the length and dimensions of self-assembled nanotubes. This allows tuning nanotube length from hundreds of nanometers to several micrometers while maintaining narrow length distributions, directly resolving the contradiction between manufacturing precision and process complexity.
Solution Approach 2:
The patent uses composite materials by combining two different dipeptide building blocks: diphenylalanine (FF) and end-capped diphenylalanine (Boc-FF or Fmoc-FF). This co-assembly approach creates hybrid nanotubes where the ratio of the two components controls the final nanotube length and structural properties, enabling precise dimensional control without complex external guidance, thus improving manufacturing precision while managing complexity.
2Adaptability or versatility
If aromatic dipeptides are used for self-assembly, then biocompatibility and chemical flexibility are achieved, but control over nanostructure dimension and length is insufficient
Solution Approach 1:
The patent maintains the chemical flexibility and biocompatibility of aromatic dipeptides while achieving precise dimensional control by changing key parameters: the molar ratio of FF to end-capped dipeptide (controlled from 9:1 to 1:9), total peptide concentration (0.1-10 mM), and solvent composition (water/ethanol ratios). These parameter adjustments enable independent control of nanotube length and diameter while preserving the inherent chemical versatility of the dipeptide system.
Solution Approach 2:
The patent introduces end-capped diphenylalanine molecules as intermediary components that act as capping agents during self-assembly. These end-capped dipeptides (Boc-FF or Fmoc-FF) serve as molecular stoppers that terminate nanotube growth at specific lengths, providing precise dimensional control while maintaining the biocompatibility and chemical flexibility of the aromatic dipeptide system.
3Strength
If uniform nanostructures with desired mechanical properties are produced, then application suitability improves, but current methods lack the capability to achieve uniform length distribution
Solution Approach 1:
The patent creates composite nanotube structures by co-assembling diphenylalanine with end-capped diphenylalanine in controlled molar ratios. This composite approach produces nanotubes with uniform length distributions and enhanced mechanical strength, as the end-capped components provide structural reinforcement and growth termination. The method achieves both uniformity (narrow length distributions with polydispersity indices <0.2) and strength (enhanced mechanical properties), resolving the contradiction between these two parameters.
Solution Approach 2:
The patent achieves uniform nanostructures with desired mechanical properties by optimizing parameter combinations: using end-capped dipeptide concentrations of 1-50% of total peptide concentration, total peptide concentrations of 0.1-10 mM, and water/ethanol solvent ratios of 9:1 to 1:9. These parameter changes produce nanotubes with controlled lengths (100 nm to 10 μm), narrow length distributions, and enhanced mechanical strength suitable for various applications including tissue engineering and drug delivery.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the production of hybrid nanostructures with enhanced mechanical strength and uniformity, making them suitable for reinforcing materials and various technological applications, including biomedicine and electronics.
Implementation Method 1
Short aromatic peptides, particularly aromatic dipeptides such as the diphenylalanine aromatic core of the β-amyloid polypeptide, have been shown to undergo self-assembly to form well-ordered hollow tubular nanostructures in aqueous solution
Implementation Method 2
The co-assembly of aromatic dipeptides, specifically Boc-FF and FF, at varying molar ratios in solution allows for controlled elongation and length distribution of tubular nanostructures
Data Source
AI summary
Nanostructures made up from two or more types of short peptides (e.g., aromatic dipeptides), which differ from one another by the presence (or absence) of an end-capping moiety, are disclosed. The disclosed nanostructures exhibit a closed tubular structure, short average length and narrow length distribution. Also disclosed are processes of preparing the nanostructures, articles comprising the nanostructures, and use of the nanostructures in, for example, reinforcement of materials.